cobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension

RxCUI
2738995
RxNorm name
cobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension
Display name
cobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension
Full name
cobicistat 90 MG / darunavir 600 MG Tablet for Oral Suspension
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PREZCOBIXDARUNAVIR ETHANOLATE AND COBICISTATJanssen Products, LP9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f2026-02-01Warnings, Adverse reactionsExact identifier
rxcui: 2738995

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9fcobicistat 90 MG / darunavir 600 MG Tablet for Oral SuspensionSCD28These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 201520260201
9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9fdarunavir 600 MG (as darunavir ethanolate ) / cobicistat 90 MG Tablet for Oral SuspensionSY28These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 201520260201
9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9fdarunavir 600 MG / cobicistat 90 MG Tablet for Oral SuspensionPSN28These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 201520260201